G&L Scientific issues draft reports within five working days of audit completion for defined audit scopes.

Built upon the strong foundation of delivering decades of industry-leading regulatory and quality services, G&L Scientific has evolved into a leading Integrated Product Development and Market Access Platform, delivering positive outcomes to patients, through a strategic combination of organic growth, strategic partnership and acquisitions. Providing a single, unified source of best-in-class solutions across the entire product pipeline; from drug and clinical development, agency interactions and regulatory submissions through to product approval, market-access, quality and compliance, business transformation and beyond.